Drugs affecting monoamines in the basal ganglia.
D000588:Amines / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001463:Barbiturates / Q000378:metabolism / Q000494:pharmacology; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism*; D001679:Biogenic Amines / Q000378:metabolism; D002247:Carbon Isotopes; D002746:Chlorpromazine / Q000378:metabolism / Q000494:pharmacology*; D003342:Corpus Striatum / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology*; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008750:Methyldopa / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D011817:Rabbits; D051381:Rats; D014149:Tranquilizing Agents / Q000378:metabolism / Q000494:pharmacology; D014316:Tritium
D000588:Amines; D001463:Barbiturates; D001679:Biogenic Amines; D002247:Carbon Isotopes; D010648:Phenylacetates; D014149:Tranquilizing Agents; D014316:Tritium; D006897:Hydroxyindoleacetic Acid; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D001285:Atropine; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine